Palisade Bio Inc (PALI)
6.36
+0.12
(+1.92%)
USD |
NASDAQ |
May 15, 14:52
Palisade Bio Shareholders Equity (Quarterly): 11.31M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.31M |
| September 30, 2023 | 14.08M |
| June 30, 2023 | 15.80M |
| March 31, 2023 | 13.75M |
| December 31, 2022 | 12.48M |
| September 30, 2022 | 12.43M |
| Date | Value |
|---|---|
| June 30, 2022 | 4.211M |
| March 31, 2022 | 4.792M |
| December 31, 2021 | 7.365M |
| September 30, 2021 | 3.92M |
| June 30, 2021 | -9.444M |
| December 31, 2020 | -16.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-16.60M
Minimum
Dec 2020
15.80M
Maximum
Jun 2023
6.174M
Average
9.339M
Median
Shareholders Equity (Quarterly) Benchmarks
| TG Therapeutics Inc | 160.11M |
| Protagenic Therapeutics Inc | 3.668M |
| Bio-Path Holdings Inc | 0.441M |
| Jaguar Health Inc | 4.961M |
| Finch Therapeutics Group Inc | 22.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.05M |
| Total Liabilities (Quarterly) | 2.739M |